読み込み中
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
前日終値
$11.68
+$0.27 · +2.37%
日中の時刻はETです。市場データは遅延する場合があります。
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
日中レンジ
現在 $11.68
52週レンジ
現在 $11.68
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
2
著しい割高
センチメント
58
まちまち
リスク
88
極めて高いリスク
モメンタム
54
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
日中レンジ
現在 $11.68
52週レンジ
現在 $11.68
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 12.53万 USD | 162.38万 USD | 162.77万 USD | 150.55万 USD | 142.07万 USD |
| 売上原価 | 7.26万 USD | 82.61万 USD | 60.92万 USD | 50.51万 USD | 48.7万 USD |
| 粗利益 | 5.27万 USD | 79.77万 USD | 101.85万 USD | 100.04万 USD | 93.37万 USD |
| 研究開発 | 214.72万 USD | 2.6万 USD | 12.23万 USD | 32.03万 USD | 31.59万 USD |
| 販売・一般管理 | 2633.06万 USD | 888.61万 USD | 905.7万 USD | 1246.96万 USD | 1170.67万 USD |
| 営業費用 | 2847.78万 USD | 1173.72万 USD | 1313.62万 USD | 2703.4万 USD | 2136.23万 USD |
| 支払利息 | — | — | — | 1065.03万 USD | — |
| 減価償却費と償却費 | 68.86万 USD | 69.57万 USD | 73.93万 USD | 131.31万 USD | 134.03万 USD |
| 営業利益 | −2842.52万 USD | −1093.95万 USD | −1211.77万 USD | −2603.37万 USD | −2042.86万 USD |
| 純利益 | −2.33億 USD | −1220.13万 USD | −1398.4万 USD | −2573.76万 USD | −1965.72万 USD |
会社概要が更新されました 2026年10月11日.
この株式へのエクスポージャーを報告している上場投資信託です。
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
